- Release Date: 03/04/23 09:40
- Summary: Entitlement Offer to raise $11m for Phase 3 clinical trial
- Price Sensitive: Yes
- Download Document 196.62KB
- Forums
- ASX - By Stock
- AVE
- Ann: Entitlement Offer to raise $11m for Phase 3 clinical trial
Ann: Entitlement Offer to raise $11m for Phase 3 clinical trial
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $12.67M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $1.219K | 406.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
35 | 77340469 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 33320021 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
35 | 77340469 | 0.003 |
25 | 69582676 | 0.002 |
10 | 57700009 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 33320021 | 21 |
0.005 | 42779777 | 22 |
0.006 | 20181009 | 14 |
0.007 | 9365221 | 8 |
0.008 | 6483888 | 6 |
Last trade - 10.00am 31/05/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online